Importantly, BEBT-908 fosters a proinflammatory tumor microenvironment, facilitating the infiltration of CD8+ cytotoxic T cells and augmenting MHC I expression in ferroptotic cancer cells. The gene discussed is CD8A; the disease is neoplasm.